SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Momenta Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: IRWIN JAMES FRANKEL who wrote (2563)10/26/2010 11:16:18 PM
From: Jeffry K. Smith  Read Replies (1) | Respond to of 3027
 
>>What I don't get about MNTA is the short interest increase.

"You might think of it as similar to covered writing."

That's just it - the covered call situation has defined, limited risk. On the other hand, shorting a stock involves (to my knowledge) unlimited risk.

If I short a stock and buy a call, I'm limiting my risk - fine. If I short a stock and sell a put above my short price, I'm increasing my basis, and covering myself to a point. There's no sense selling a put below where I've shorted the stock, so unless I've missed a possibility, I don't understand how you can relate the two strategies.

I'd sure appreciate an example of why you feel the two are similar strategies (riskwise).



To: IRWIN JAMES FRANKEL who wrote (2563)10/27/2010 8:19:32 AM
From: tom pope  Respond to of 3027
 
delta hedge the movement.

It's always seemed to me that delta hedging is more difficult in practice than in theory, unless you're on a professional desk. For the retail investor transaction costs including friction are a big barrier to successful implementation of the strategy, esp if the stock is volatile and calls for frequent hedge adjustments.